Adma Biologics reported $0.15 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Adma Biologics USD 0.15 0.01 Sep/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
BioCryst Pharmaceuticals USD -0.13 0.06 Dec/2024
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Novavax USD -0.76 1.76 Sep/2024
Omeros USD -1.12 0.37 Jun/2024
Takeda JPY 65.74 73.57 Dec/2025